Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study
Rajme-López, Sandra, Martinez-Guerra, Bernardo A, Román-Montes, Carla M, Tamez-Torres, Karla M, Tello-Mercado, Andrea C, Tepo-Ponce, Karen M, Segura-Ortíz, Zurisadai, López-Aguirre, Abigail, Gutiérrez-Mazariegos, Orianlid Del Rocío, Lazcano-Delgadillo, Oswaldo, Nares-López, Rafael, González-Lara, María F, Kershenobich-Stalnikowitz, David, Sifuentes-Osornio, José, Ponce-de-León, Alfredo, Ruíz-Palacios, Guillermo M
Published in Therapeutic advances in infectious disease (01.01.2024)
Published in Therapeutic advances in infectious disease (01.01.2024)
Get full text
Journal Article